These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3406046)

  • 21. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
    Dyson MC; Bellan JA; Minkes RK; Beckerman RC; Wegmann MJ; Braquet P; McNamara DB; Kadowitz PJ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1320-7. PubMed ID: 2175802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonism of thromboxane receptor induced contractions in isolated human groin lymphatics.
    Sjöberg T; Andersson KE; Norgren L; Steen S
    Lymphology; 1989 Sep; 22(3):135-40. PubMed ID: 2532276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BM 13.505, a selective thromboxane receptor antagonist, reduces myocardial infarct size following coronary artery reperfusion.
    Smith EF; Earl CQ; Egan JW
    Prostaglandins Leukot Essent Fatty Acids; 1989 Oct; 38(1):15-23. PubMed ID: 2532749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Close-arterial administration of the thromboxane mimetic U-46619 induces damage to the rat gastric mucosa.
    Esplugues JV; Whittle BJ
    Prostaglandins; 1988 Feb; 35(2):137-48. PubMed ID: 2966419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboxane-mimetic U46619 causes depressor responses in anaesthetized rats.
    Hui SG; Ogle CW
    J Pharm Pharmacol; 1991 Aug; 43(8):592-3. PubMed ID: 1681077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of daltroban, a thromboxane (TX) A2 receptor antagonist, on lipid metabolism and atherosclerosis.
    Pill J; Metz J; Stegmeier K; Hartig F
    Agents Actions Suppl; 1992; 37():107-13. PubMed ID: 1632287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease.
    Fiedler VB; Seuter F; Perzborn E
    Stroke; 1990 Dec; 21(12 Suppl):IV149-51. PubMed ID: 2260140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective actions of a new potent thromboxane receptor antagonist in arachidonate induced sudden death.
    Liao P; Johnson G; Siegfried M; Lefer AM
    Eicosanoids; 1989; 2(1):33-7. PubMed ID: 2534470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
    Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
    Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of renal vasoconstriction with thromboxane mimetic: engagement of tubuloglomerular feedback.
    Welch WJ; Wilcox CS; Folger WH
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():693-6. PubMed ID: 1825399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H; Yanagisawa A; Lefer AM
    Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of putative thromboxane receptor agonists and antagonists on rat small intestinal ion transport.
    Smith PL; McCafferty GP; Fondacaro JD; Wasserman MA; Elton E; Ryan FM
    J Pharmacol Exp Ther; 1988 Oct; 247(1):143-9. PubMed ID: 2971796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daltroban blocks thromboxane responses in the pulmonary vascular bed of the cat.
    Hood JS; Nossaman BD; Ibrahim IN; McMahon TJ; Babycos CR; Kadowitz PJ
    J Appl Physiol (1985); 1992 Jun; 72(6):2305-10. PubMed ID: 1385804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of vagal contractile response by thromboxane mimetic U-46619.
    Munoz NM; Shioya T; Murphy TM; Primack S; Dame C; Sands MF; Leff AR
    J Appl Physiol (1985); 1986 Sep; 61(3):1173-9. PubMed ID: 3759757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
    Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J
    Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
    [No Abstract]   [Full Text] [Related]  

  • 37. Preventive effect of monatepil on thromboxane A2 agonist-induced myocardial ischemia in rats.
    Yamamoto T; Hosoki K; Kikuta C; Karasawa T
    Arzneimittelforschung; 1994 Jun; 44(6):712-4. PubMed ID: 8053969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase inhibitors blunt thromboxane action in human placental arteries by blocking thromboxane receptors.
    Wilkes BM; Hollander AM; Sung SY; Mento PF
    Am J Physiol; 1992 Oct; 263(4 Pt 1):E718-23. PubMed ID: 1415690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central thromboxane receptors: mRNA expression and mediation of pressor responses.
    Gao H; Peng B; Welch WJ; Wilcox CS
    Am J Physiol; 1997 May; 272(5 Pt 2):R1493-500. PubMed ID: 9176341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct myocardial effects of the thromboxane A2/prostaglandin H2 agonists U-46619 and SQ 26,655 under ischemic and nonischemic conditions.
    Grover GJ; Hedberg A; Ogletree ML
    Pharmacology; 1990; 41(1):1-15. PubMed ID: 2122481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.